Atlas Trials

Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan

Clinical trial NCT02835742 · COMPLETED

Trial details

NCT number
NCT02835742
Sponsor
Niigata University Medical & Dental Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Alveolar Proteinosis, Autoimmune
Start date
2016-09-01
Primary completion
2017-08-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.